Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Omagh laboratory to remain open
sheep
"The Omagh facility is of paramount importance. Without it vast areas to the west of the province would be left without effective surveillance."
Budget cuts led to possible closure of the centre

Veterinary organisations have welcomed the news that a diagnostic laboratory in Omagh, Co Tyrone, will remain open.

The lab plays a key role in the prevention, detection and monitoring of animal diseases in Northern Ireland.

It was being considered for closure due to financial pressures on the Department of Agriculture and Rural Development and the Agri-Food and Biosciences Institute. This follows similar cut-backs in surveillance facilities elsewhere in the UK.

Simon Doherty, president of the BVA's Northern Ireland branch, said: "The Omagh facility is of paramount importance. Without it vast areas to the west of the province would be left without effective surveillance."

Whilst BVA (NI) and the Northern Ireland Veterinary Association acknowledged the financial pressures facing DARD and AFBI, Mr Doherty said: "Our high-level concerns are in maintaining adequate levels of disease surveillance and investigation, diagnostic services to support a local industry with a huge export market, food safety, and the ability to protect the interests of that industry in an emergency response situation, should an epizootic disease outbreak occur."

BVA president John Blackwell also stressed the importance of maintaining adequate disease surveillance, noting: "The whole industry and wider society benefits by being in a state of readiness and preparedness for an epizootic outbreak underpinning both animal and public health."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.